APA (7th ed.) Citation

E, B., M, A., A, G., MR, T., S, B., CJ, P., & J, B. (2024). Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol. Journal of the American College of Cardiology, 84(14), 1328. https://doi.org/10.1016/j.jacc.2024.07.034

Chicago Style (17th ed.) Citation

E, Björnson, Adiels M, Gummesson A, Taskinen MR, Burgess S, Packard CJ, and Borén J. "Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol." Journal of the American College of Cardiology 84, no. 14 (2024): 1328. https://doi.org/10.1016/j.jacc.2024.07.034.

MLA (9th ed.) Citation

E, Björnson, et al. "Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol." Journal of the American College of Cardiology, vol. 84, no. 14, 2024, p. 1328, https://doi.org/10.1016/j.jacc.2024.07.034.